Skip to main content
. 2013 Nov 6;34(12):1157–1165. doi: 10.1097/MNM.0b013e328365d99b

Fig. 1.

Fig. 1

The average biological serum clearance curve for 68Ga-DOTA-F(ab′)2-trastuzumab from all 15 patients is plotted with SDs in both the time and %ID/l serum axis. 68Ga-DOTA-F(ab′)2-trastuzumab, 68Ga-1,4,7,10-tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid (DOTA)-F(ab′)2-trastuzumab.